Infant Formula Fat Composition with OPO Triglycerides

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current infant formula fat compositions derived from vegetable sources do not accurately match the fatty acid distribution found in human milk fat, particularly in the 2-position of glycerides, which is crucial for dietary compatibility and are not cost-effective for global use, including blending with dairy products.

Innovation Solution

A fat composition is produced by blending OPO-rich fat, palm kernel oil, and medium chain triglyceride oil, with specific fatty acid distribution to mimic human milk fat, including at least 40% of palmitic acid in the 2-position, and used in infant formulas with cow's milk-derived fat, ensuring compatibility and cost-effectiveness.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If vegetable oils and fats are used to produce milk replacement fat compositions, then the fat composition can be produced from renewable sources, but the fatty acid distribution does not match human milk fat composition

Engineering Contradiction:
Improvedietary compatibilityVSAvoidfatty acid distribution
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent changes the positional parameters of fatty acids in triglyceride molecules through enzymatic interesterification. A 1,3-specific lipase is used to selectively place palmitic acid at the 2-position and unsaturated fatty acids at the 1- and 3-positions, transforming the molecular structure to match human milk fat composition while using vegetable oil sources.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces conventional chemical interesterification methods with enzymatic interesterification using 1,3-specific lipases. This biological catalyst system provides regiospecific activity that mechanically achieves the desired fatty acid distribution pattern without requiring harsh chemical conditions, thereby improving manufacturing precision of fatty acid placement.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Manufacturing precision

If conventional enzymatic processes with 1,3-specific lipases are used to produce OPO triglycerides, then palmitic acid can be placed at the 2-position, but the production cost increases

Engineering Contradiction:
Improvepalmitic acid positioningVSAvoidproduction cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent optimizes reaction parameters including temperature (30-70°C), pH (6.0-8.0), and water activity (0.05-0.65) to enhance lipase activity and selectivity. By carefully controlling these parameters, the process achieves high 1,3-specificity and OPO triglyceride yield while reducing enzyme loading requirements and processing time, thereby lowering production costs.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent performs preliminary preparation of the reaction system by pre-mixing substrates, adjusting water activity, and optimizing pH before adding the lipase catalyst. This preliminary action ensures that when the enzymatic reaction begins, all conditions are optimal for 1,3-specific activity, maximizing efficiency and reducing overall process time and cost.

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If the fatty acid composition is modified to match human milk fat, then nutritional equivalence is improved, but the complexity of the production process increases

Engineering Contradiction:
Improvenutritional equivalenceVSAvoidproduction process complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent segments the complex task of matching human milk fat composition by focusing on the most critical parameter: the positional distribution of palmitic acid and unsaturated fatty acids in triglycerides. By targeting specifically the 1,3-dioleoyl-2-palmitoyl (OPO) triglyceride formation, the process achieves nutritional equivalence without needing to replicate all aspects of human milk fat composition, thereby simplifying production.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution provides a fat composition that closely matches human milk fat, enhancing dietary compatibility and cost-effectiveness for global use, particularly in infant formulas, ensuring nutritional equivalence and ease of production from vegetable sources.

Implementation Method 1

these fat compositions can be obtained by subjecting fatty mixtures comprising glycerides consisting substantially of more saturated 2-palmitoyl glycerides to a rearrangement catalyst, such as a lipase, which is regiosspecific in activity in the 1- and 3-positions of the glycerides. Under the influence of the catalyst, unsaturated fatty acid residues may be introduced into the 1- and 3-positions of the 2-palmitoyl glycerides by exchange with unsaturated free fatty acids or their alkyl esters.

Methodology Applied
Scientific EffectEnzymatic interesterification: Enzyme

Data Source

PatentEP2956010B2Fat composition
Publication Date: 2022.12.21 BUNGE LODERS CROKLAAN BV

AI summary

A fat composition having the following fatty acid content: - from 2 to 5% C8:0 - from 1 to 5% C10:0 - from 2 to 10% C12:0 - from 1 to 5% C14:0 - from 15 to 30% C16:0 - from 1 to 7% C 18:0 - from 25 to 45% C18:1 - from 15 to 30% C18:2, and - from 0.5 to 5% C 18: 3, said percentages being by weight based on total C8 to C24 fatty acids present in the fat composition, wherein at least 33% of total C16:0 is bound to the sn-2 position in a glyceride. The fat composition may be used in an infant formula.